×
About 4,515 results

ALLMedicine™ Intrauterine Device Center

Research & Reviews  2,121 results

Risk of precancerous cervical lesions in women using a hormone-containing intrauterine ...
https://doi.org/10.1093/humrep/deab066
Human Reproduction (Oxford, England); Skorstengaard M, Lynge E et. al.

May 11th, 2021 - Is the risk of high-grade precancerous cervical lesions and/or is the risk of lesion progression increased in users of a hormone-containing intrauterine device (HIUD) compared with users of other contraceptive methods. Women starting use of HIUD h...

Major differences in the characteristics of users of the copper intrauterine device or ...
https://doi.org/10.1002/ijgo.13716
International Journal of Gynaecology and Obstetrics: the ... Laporte M, Metelus S et. al.

Apr 19th, 2021 - To compare the sociodemographic characteristics of users of the copper intrauterine device (Cu-IUD) and the levonorgestrel intrauterine system (LNG-IUS) at a family planning clinic in Campinas, SP, Brazil. A retrospective audit study was conducted...

Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine devi...
https://doi.org/10.1080/13625187.2021.1900565
The European Journal of Contraception & Reproductive Heal... Ali MK, Ramadan AK et. al.

Apr 15th, 2021 - To compare the outcomes of trans-abdominal ultrasound (TAS) guided approach and uterine sound-sparing approach (USSA) during copper intrauterine device (IUD) insertion. A randomised open-label clinical trial (Clinical Trials.Gov: NCT03383432) incl...

The efficacy of amniotic membrane-mediated sequential double-barrier therapy for the tr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051972
Medicine Wu C, Dong Y et. al.

Apr 13th, 2021 - To study the efficacy of using amniotic membrane, balloon and intrauterine device (IUD) as barrier therapy to prevent re-adhesion after hysteroscopic adhesiolysis.A total of 45 patients diagnosed with intrauterine adhesions in Changzhou Maternal a...

see more →

Guidelines  5 results

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
https://journals.lww.com/greenjournal/Fulltext/2019/01000/Five_Year_Contraceptive_Efficacy_and_Safety_of_a.11.aspx

Dec 31st, 2018 - A phase 3 study of a levonorgestrel 52-mg intrauterine system in U.S. females shows high 5-year contraceptive efficacy and low hormonal adverse effect rates. In the United States, 45% of pregnancies each year are unintended.1 Females who use long-...

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Adolescents-and-Long-Acting-Reversible-Contraception
Committee on Adolescent Health Care

Apr 30th, 2018 - The phenomenon of adolescent childbearing is complex and far reaching, affecting not only the adolescents but also their children and their community. The prevalence and public health effect of adolescent pregnancy reflect complex structural socia.

Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices.
https://doi.org/10.1016/j.contraception.2017.09.014
Contraception Whitaker AK, Chen BA

Oct 10th, 2017 - Postplacental intrauterine device (IUD) placement, defined as IUD placement within 10 min after delivery of the placenta, is an appealing strategy for increasing access to postpartum IUDs because it does not require a separate postpartum visit. Th...

Best practices to minimize risk of infection with intrauterine device insertion.
https://doi.org/10.1016/S1701-2163(15)30636-8
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Caddy S, Yudin MH et. al.

Mar 12th, 2014 - Intrauterine devices provide an extremely effective, long-term form of contraception that has the benefit of being reversible. Historically, the use of certain intrauterine devices was associated with increased risk of pelvic inflammatory disease....

Therapeutic management of uterine fibroid tumors: updated French guidelines.
https://doi.org/10.1016/j.ejogrb.2012.07.030
European Journal of Obstetrics, Gynecology, and Reproduct... Marret H, Fritel X et. al.

Sep 3rd, 2012 - The medical management of symptomatic non-submucosal uterine fibroid tumors (leiomyomas or myomas) is based on the treatment of abnormal uterine bleeding by any of the following: progestogens, a levonorgestrel-releasing intrauterine device, tranex...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  2,223 results

Risk of precancerous cervical lesions in women using a hormone-containing intrauterine ...
https://doi.org/10.1093/humrep/deab066
Human Reproduction (Oxford, England); Skorstengaard M, Lynge E et. al.

May 11th, 2021 - Is the risk of high-grade precancerous cervical lesions and/or is the risk of lesion progression increased in users of a hormone-containing intrauterine device (HIUD) compared with users of other contraceptive methods. Women starting use of HIUD h...

Hormonal Intrauterine Device Under Study for Managing Early Endometrial Cancer
https://ascopost.com/issues/may-10-2021/hormonal-intrauterine-device-under-study-for-managing-early-endometrial-cancer/

May 9th, 2021 - Disease regression was observed in 82% of women with endometrial hyperplasia with atypia and 43% of women with endometrial cancer after treatment for 6 months with a hormonal intrauterine device in a phase II study reported during the virtual edit...

Kyleena - levonorgestrel intrauterine device-Bayer HealthCare Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e07c155-21e1-4781-9633-ce8bddd47080

Apr 29th, 2021 - Kyleena is indicated to prevent pregnancy for up to 5 years. Replace the system after 5 years if continued use is desired. Kyleena is a progestin-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 5 years. (1)

Major differences in the characteristics of users of the copper intrauterine device or ...
https://doi.org/10.1002/ijgo.13716
International Journal of Gynaecology and Obstetrics: the ... Laporte M, Metelus S et. al.

Apr 19th, 2021 - To compare the sociodemographic characteristics of users of the copper intrauterine device (Cu-IUD) and the levonorgestrel intrauterine system (LNG-IUS) at a family planning clinic in Campinas, SP, Brazil. A retrospective audit study was conducted...

Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine devi...
https://doi.org/10.1080/13625187.2021.1900565
The European Journal of Contraception & Reproductive Heal... Ali MK, Ramadan AK et. al.

Apr 15th, 2021 - To compare the outcomes of trans-abdominal ultrasound (TAS) guided approach and uterine sound-sparing approach (USSA) during copper intrauterine device (IUD) insertion. A randomised open-label clinical trial (Clinical Trials.Gov: NCT03383432) incl...

see more →

News  149 results

Levonorgestrel IUD Effective as Emergency Contraception
https://www.medscape.com/viewarticle/945354

Feb 4th, 2021 - A levonorgestrel 52-mg intrauterine device (IUD) is noninferior to a copper IUD for emergency contraception, according to randomized trial results published online in The New England Journal of Medicine. Although the trial didn't directly compare ...

LARC Prescribing Trends in Scotland
https://www.medscape.com/viewarticle/938155

Sep 27th, 2020 - Public Health Scotland has published the data for 2019-2020 on the prescription of long-acting reversible methods of contraception (LARC) to women aged 15-49 years in primary care and sexual health settings. LARC includes contraceptive implant, in...

Vacuum Device Quickly Stops Postpartum Hemorrhage
https://www.staging.medscape.com/viewarticle/937540

Sep 16th, 2020 - A novel intrauterine device that uses suction to compress the uterus to control postpartum hemorrhage has received high marks for effectiveness and ease of use, researchers say. Dr James Byrne Calling this approach "a stroke of brilliance," James ...

Vacuum Device Quickly Stops Postpartum Hemorrhage
https://www.medscape.com/viewarticle/937540

Sep 16th, 2020 - A novel intrauterine device that uses suction to compress the uterus to control postpartum hemorrhage has received high marks for effectiveness and ease of use, researchers say. Calling this approach "a stroke of brilliance," James Byrne, MD, told...

IUD Placement Likely Safe Even if Pregnancy Test Criteria Unmet
https://www.medscape.com/viewarticle/924331

Jan 28th, 2020 - NEW YORK (Reuters Health) - Clinicians need not withhold intrauterine device (IUD) placement based on pregnancy checklist criteria, a cohort study reveals. "The pregnancy checklist...serves as a great starting point for guiding a discussion about ...

see more →